ENDPOINTS NEWS21d
Elu­ci­da On­col­o­gy, seek­ing foothold in AD­Cs, shut­ters due to 'lack of fund­ing'
Elu­ci­da On­col­o­gy, a clin­i­cal-stage biotech led by for­mer Pfiz­er ex­ec­u­tive Geno Ger­mano, has shut down, End­points News has learned.